Attitude towards genetic testing for breast cancer susceptibility: a comparison of affected and unaffected women

被引:15
|
作者
Bruno, M. [1 ]
Digennaro, M. [2 ]
Tommasi, S. [1 ]
Stea, B. [1 ]
Danese, T. [1 ]
Schittulli, F. [2 ]
Paradiso, A. [1 ]
机构
[1] Canc Inst Bari, Dept Expt Oncol, Bari, Italy
[2] Canc Inst Bari, Woman Dept, Unit Senol, Bari, Italy
关键词
breast cancer; genetic testing; family health history; interest; survey; BRCA1 MUTATION CARRIERS; OVARIAN-CANCER; GENERAL-POPULATION; HEREDITARY BREAST; FAMILY-HISTORY; RISK; DECISIONS; KNOWLEDGE; PERCEPTIONS; AWARENESS;
D O I
10.1111/j.1365-2354.2009.01067.x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The objective of this study is to evaluate women's awareness and interest in genetic testing for breast cancer risk, to identify socio-demographic factors, to analyse the reasons for wanting or not wanting to be tested and finally to determine whether breast cancer patients and healthy women have different attitudes towards genetic testing. Consecutive series of 879 women without and with breast cancer participated in a 20-item self-completing questionnaire. Among breast cancer patients, 57% answered that they would definitely or probably accept being tested, compared with 84% of women without breast cancer. At the multiple logistic regression analysis only to have a diagnosis of breast cancer conditioned significantly the interest to have genetic testing. Surprisingly, a family history of breast cancer was found to have no significant impact. The most frequently cited reason for being interested in genetic testing was 'to learn about your children's risk'. Although women's awareness about breast cancer genes is inadequate, the interest in genetic testing is substantial and higher both in healthy women and in women with breast cancer. These results provide important indications for the development of educational strategies.
引用
收藏
页码:360 / 368
页数:9
相关论文
共 50 条
  • [31] Acceptance of testing for genetic predisposition to breast cancer: The attitude of medical professionals
    Simeonov, E
    Shopova, S
    Dimitrov, B
    DISEASE MARKERS, 1999, 15 (1-3) : 155 - 155
  • [32] Genetic testing in women with breast cancer: implications for treatment
    Paterson, Robin
    Phillips, Kelly-Anne
    EXPERT REVIEW OF ANTICANCER THERAPY, 2017, 17 (11) : 991 - 1002
  • [33] Optimizing genetic testing in Hispanic women with breast cancer
    Garcia, Allysa Lynn
    Akula, Niklesh
    Derrick, Daniel Kade
    Worrell, Christopher M.
    Lakhotia, Simren
    Menon, Shwetha
    Lathrop, Kate
    CANCER RESEARCH, 2022, 82 (04)
  • [34] 'A Low Risk Is Still a Risk': Exploring Women's Attitudes towards Genetic Testing for Breast Cancer Susceptibility in Order to Target Disease Prevention
    Henneman, L.
    Timmermans, D. R.
    Bouwman, C. M.
    Cornel, M. C.
    Meijers-Heijboer, H.
    PUBLIC HEALTH GENOMICS, 2011, 14 (4-5) : 238 - 247
  • [35] Attitudes and interest in genetic testing for breast and ovarian cancer susceptibility in diverse groups of women in western Washington
    Durfy, SJ
    Bowen, DJ
    McTiernan, A
    Sporleder, J
    Burke, W
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 1999, 8 (04) : 369 - 375
  • [36] Psychological impact of genetic testing for breast cancer susceptibility in women of Ashkenazi Jewish background: A prospective study
    Andrews, L
    Meiser, B
    Apicella, C
    Tucker, K
    GENETIC TESTING, 2004, 8 (03): : 240 - 247
  • [37] Can a computer-based system be used to educate women on genetic testing for breast cancer susceptibility?
    Schwartz, MD
    Tercyak, KP
    Peshkin, BN
    Valdimarsdottir, H
    NATURE CLINICAL PRACTICE ONCOLOGY, 2005, 2 (01): : 24 - 25
  • [38] Can a computer-based system be used to educate women on genetic testing for breast cancer susceptibility?
    Marc D Schwartz
    Kenneth P Tercyak
    Beth N Peshkin
    Heiddis Valdimarsdottir
    Nature Clinical Practice Oncology, 2005, 2 : 24 - 25
  • [40] Characterizing Genetic Susceptibility to Breast Cancer in Women of African Ancestry
    Feng, Ye
    Rhie, Suhn Kyong
    Huo, Dezheng
    Ruiz-Narvaez, Edward A.
    Haddad, Stephen A.
    Ambrosone, Christine B.
    John, Esther M.
    Bernstein, Leslie
    Zheng, Wei
    Hu, Jennifer J.
    Ziegler, Regina G.
    Nyante, Sarah
    Bandera, Elisa V.
    Ingles, Sue A.
    Press, Michael F.
    Deming, Sandra L.
    Rodriguez-Gil, Jorge L.
    Zheng, Yonglan
    Yao, Song
    Han, Yoo-Jeong
    Ogundiran, Temidayo O.
    Rebbeck, Timothy R.
    Adebamowo, Clement
    Ojengbede, Oladosu
    Falusi, Adeyinka G.
    Hennis, Anselm
    Nemesure, Barbara
    Ambs, Stefan
    Blot, William
    Cai, Qiuyin
    Signorello, Lisa
    Nathanson, Katherine L.
    Lunetta, Kathryn L.
    Sucheston-Campbell, Lara E.
    Bensen, Jeannette T.
    Chanock, Stephen J.
    Le Marchand, Loic
    Olshan, Andrew F.
    Kolonel, Laurence N.
    Conti, David V.
    Coetzee, Gerhard A.
    Stram, Daniel O.
    Olopade, Olufunmilayo I.
    Palmer, Julie R.
    Haiman, Christopher A.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2017, 26 (07) : 1016 - 1026